Drugmaker telehealth deals risk unnecessary prescribing, Senate probe finds
- Posted on July 17, 2025
- By Washington Post
- 1 Views
Drugmaker telehealth deals risk unnecessary prescribing, Senate probe finds
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to pharmaceutical companies Pfizer and Eli Lilly.
